Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 279-482-1 | CAS number: 80480-24-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981-05-01 to 1982-10-15
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: study was not conducted under GLP but performed according to existing test prodecures (Ames et al. 1977).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- The study was conducted according to Ames et al. (1978) and followed the main principles of the later OECD TG 471 (first adopted 26 May 1983).
- GLP compliance:
- no
- Remarks:
- GLP in EU started in 1981
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Troenan
- IUPAC Name:
- Troenan
- Test material form:
- other: not reported
- Details on test material:
- - Name of test material (as cited in study report): Troenan
Constituent 1
Method
- Target gene:
- gene for synthesis of Histidin in strains of Salmonella typhimurium
Species / strainopen allclose all
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- other: Mutations in Histidin synthesis: his G46 in TA 1535 and TA 100, his C 3076 in TA 1537, his D3052 in TA 98; additional mutations: rfa (LPS), uvrB (repair), R- in TA 1535 and TA 1537, R- in TA 100 and TA 98
- Species / strain / cell type:
- S. typhimurium TA 1538
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- other: Mutations in Histidin synthesis:his D3052 in TA 1538; additional mutations: rfa (LPS), uvrB (repair), R- in TA 1538
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 mix
- Test concentrations with justification for top dose:
- 4, 20, 100, 500 and 2500 µg/L
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: not reported
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- other: 2-aminoantracen
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: bacteria suspension in 10 mL standard I nutrition bouillon, cell concnetration 10^9
2 mL Top Agar (including 10 mL sterile Histidin (0.5 mM)-Biotin (0.5 mM)-solution per 100 mL Top Agar), 0.1 mL bacteria suspension, 0.1 mL test substance solution were transferred into sterile vessels and thoroughl y mixed.
5 test concentrations without S9-mix: addition of 0.5 mL sterile water
5 test concentrations with S9-mix: addition of 0.5 mL S9-mix
After mixing dirstibuten of the soft fluid into Agar plates
- Exposure duration: 48 hours
- Expression time (cells in growth medium): 48 hours
- Selection time (if incubation with a selection agent): not applicable
- Fixation time (start of exposure up to fixation or harvest of cells): not applicable
SELECTION AGENT (mutation assays): not applicable
SPINDLE INHIBITOR (cytogenetic assays): not applicable
STAIN (for cytogenetic assays): not applicable
NUMBER OF REPLICATIONS: 2
NUMBER OF CELLS EVALUATED: not reported
DETERMINATION OF CYTOTOXICITY: relative total growth - Evaluation criteria:
- Assessment of a positive result:
- background of not reverted bacteria with no growth reduction in comparison to the negative controls
- spontaneous mutation rates of the used bacteria strains within the charactictic range of spontaneous mutations
range of spontaneoas mutations without S-9 mix:
TA 1535: mean = 6, extreme values: 1-15 (Ames at al.: mean=20, extreme values 5-50)
TA 100: mean = 87, extreme values: 35-201 (Ames at al.: mean=160, extreme values 60-220)
TA 1537: mean = 7, extreme values: 1-24 (Ames at al.: mean=7, extreme values 3-25)
TA 1538: mean = 14, extreme values: 6-27 (Ames at al.: mean=25, extreme values 5-40)
TA 98: mean = 20, extreme values: 5-39 (Ames at al.: mean=40, extreme values 15-75)
range of spontaneoas mutations with S-9 mix:
TA 1535: mean = 8, extreme values: 1-25
TA 100: mean = 105, extreme values: 54-252
TA 1537: mean = 6, extreme values: 1-23
TA 1538: mean = 18, extreme values: 3-48
TA 98: mean = 27, extreme values: 7-76
- positive controls with mutation rates of at least 2.0 (TA 100) and 3.0 (other strains)
- an effect is considered if the test substance causes an increase of spontaneous mutations relative to the negative controls of at least 2.0 (TA 100) or 3.0 (other strains)
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- S. typhimurium TA 1538
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Table 1 Number of revertants in cultures without S-9 mix
Treatment | Conc. | TA1535 | TA100 | TA1537 | TA1538 | TA98 | |||||
(without S-9 mix) | (µg/plate) | mean | SD | mean | SD | mean | SD | mean | SD | mean | SD |
negative control | --- | 4.5 | 2.3 | 100.5 | 15.1 | 4.2 | 1.5 | 9.3 | 3.8 | 13 | 3.6 |
positive controls | |||||||||||
sodium azide | 1 | 276.7 | 107.9 | 489.3 | 231.9 | --- | --- | --- | --- | --- | --- |
F-factor | --- | 61.5 | --- | 4.9 | --- | --- | --- | --- | --- | --- | --- |
4-nitrol-o-phenylendiamin | --- | --- | --- | --- | --- | 109.7 | 40 | 1084 | 56 | 472 | 205 |
F-factor | --- | --- | --- | --- | --- | 26.1 | --- | 116.6 | --- | 36.6 | --- |
2-aminoanthracene | 5 | 3 | 1 | 106.3 | 14.7 | 6.7 | 1.6 | 16.7 | 9.9 | 18.3 | 0.6 |
test substance | |||||||||||
Troenan | 2500 | 2 | 0 | 40 | 14.1 | ---a | ---a | ---a | ---a | 12 | 4.2 |
500 | 2 | 1.4 | 62.5 | 9.2 | ---a | ---a | 7.5 | 3.5 | 6 | 1.4 | |
100 | 3 | 0 | 61 | 9.9 | 3.5 | 0.7 | 10 | 0 | 11.5 | 4.9 | |
20 | 1.5 | 0.7 | 70.5 | 3.5 | 3.5 | 0.7 | 7.5 | 2.1 | 12.5 | 3.5 | |
4 | 2 | 1.4 | 66 | 5.7 | 4 | 1.4 | 11 | 2.8 | 7 | 2.8 |
F-factor: increase of revertants relative to the negative control
a. Partial or complete inhibition of bacterial growth
Table 2 Number of revertants in cultures with S-9 mix
Treatment | Conc. | TA1535 | TA100 | TA1537 | TA1538 | TA98 | |||||
(with S-9 mix) | (µg/plate) | mean | SD | mean | SD | mean | SD | mean | SD | mean | SD |
negative control | --- | 9.2 | 4.3 | 95.3 | 21.1 | 11.3 | 21.6 | 18.4 | 5.5 | 23.7 | 7.7 |
positive controls | |||||||||||
sodium azide | 1 | 26.3 | 3.1 | 85.7 | 30.2 | --- | --- | --- | --- | --- | --- |
F-factor | --- | 2.9 | --- | --- | --- | --- | --- | --- | --- | --- | --- |
4-nitrol-o-phenylendiamin | --- | --- | --- | --- | --- | 41 | 11.5 | 985 | 127 | 709 | 10 |
F-factor | --- | --- | --- | --- | --- | 3.6 | --- | 53.6 | --- | 29.9 | --- |
2-aminoanthracene | 5 | 55 | 9.5 | 1079 | 341 | 591 | 120 | 440 | 74 | 1404 | 366 |
F-factor | --- | 6 | --- | 11.3 | --- | 52.4 | --- | 23.9 | --- | 59.2 | --- |
test substance | |||||||||||
Troenan | 2500 | 4 | 0 | 109 | 1.1 | ---a | ---a | 19 | 8.5 | 23 | 0 |
500 | 5 | 0 | 92.5 | 31.8 | ---a | ---a | 18 | 7.1 | 27 | 2.8 | |
100 | 7 | 2.8 | 82.5 | 23.3 | 6 | 0 | 21 | 4.2 | 28 | 0 | |
20 | 2 | 0 | 90 | 35.3 | 5.5 | 0.7 | 16.5 | 4.9 | 23.5 | 0.7 | |
4 | 10 | 0 | 84.5 | 2.1 | 6 | 2.8 | 29 | 1.4 | 24 | 5.7 |
F-factor: increase of revertants relative to the negative control
a. Partial or complete inhibition of bacterial growth
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
In a reliable and conclusive study according to Ames et al. (1977), the test substance Troenan is considered to be not mutagenic under the conditions of the test. - Executive summary:
The test substance Troenan was tested for mutagenic activity in the bacterial tester strains Samonella typhimurium TA 1535, TA 100, TA 1537, TA 1538 and TA 98. The test was conducted on agar plates in the absence or presence pf postmitochondrial supernatant fluids from the liver of male rates treated with Aroclor 1254 (S-9 mix). Solutions of the test substance were freshly made up in DMSO before use. The following test concentrations were tested: 4. 20, 100, 500 and 2500 µg Troenan per plate.Troenan did not induce reverse mutations in the absence or presence of S-9 mix in the tester strains TA 1535, TA 100, TA 1537, TA 1538 and TA 98. Therefore, Troenan did not show mutagernic activity in vitro.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.